# EDGAR Filing Document

**Accession Number:** 0001337013
**File Stem:** 0001628280-23-009569
**Filing Date:** 2023-3
**Character Count:** 6071
**Document Hash:** c837902e2ab9f5a10fa3eaddc24011e6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-23-009569.hdr.sgml**: 20230328

**ACCESSION NUMBER**: 0001628280-23-009569

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230324

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20230328

**DATE AS OF CHANGE**: 20230328

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** InfuSystem Holdings, Inc
- **CENTRAL INDEX KEY:** 0001337013
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 203341405
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35020
- **FILM NUMBER:** 23770512

**BUSINESS ADDRESS:**
- **STREET 1:** 3851 WEST HAMLIN ROAD
- **CITY:** ROCHESTER HILLS
- **STATE:** MI
- **ZIP:** 48309
- **BUSINESS PHONE:** (248) 291-1210

**MAIL ADDRESS:**
- **STREET 1:** 3851 WEST HAMLIN ROAD
- **CITY:** ROCHESTER HILLS
- **STATE:** MI
- **ZIP:** 48309

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HAPC, Inc.
- **DATE OF NAME CHANGE:** 20060425

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Healthcare Acquisition Partners Corp.
- **DATE OF NAME CHANGE:** 20050824

?xml version="1.0" ? infu-20230324

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**___________________________________**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

**Date of Report (date of earliest event reported): March 24, 2023**

**___________________________________**

**InfuSystem Holdings, Inc.**

(Exact name of registrant as specified in its charter)

**___________________________________**

---

| | | |
|:---|:---|:---|
| **Delaware**<br>(State or other jurisdiction of <br>incorporation or organization) | **001-35020**<br>(Commission File Number) | **20-3341405**<br>(I.R.S. Employer Identification Number) |
| **3851 West Hamlin Road**<br>**Rochester Hills, Michigan 48309** | **3851 West Hamlin Road**<br>**Rochester Hills, Michigan 48309** | **3851 West Hamlin Road**<br>**Rochester Hills, Michigan 48309** |
| &nbsp;&nbsp;&nbsp;&nbsp;(Address of principal executive offices) (Zip Code) | &nbsp;&nbsp;&nbsp;&nbsp;(Address of principal executive offices) (Zip Code) | &nbsp;&nbsp;&nbsp;&nbsp;(Address of principal executive offices) (Zip Code) |
| **248 291-1210** | **248 291-1210** | **248 291-1210** |
| (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) |
|  | **Not Applicable** |  |
| (Former Name or Former Address, if Changed Since Last Report) | (Former Name or Former Address, if Changed Since Last Report) | (Former Name or Former Address, if Changed Since Last Report) |

---

**___________________________________**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

**☐** Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

**☐** Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

**☐** Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

**☐** Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

| | | |
|:---|:---|:---|
| **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Title of Each Class** | **Trading Symbol(s)** | **Name of Each Exchange on which Registered** |
| **Common Stock, par value $.0001 per share** | **INFU** | **NYSE American LLC** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers**

On March 24, 2023, Christopher Sansone notified InfuSystem Holdings, Inc. (the "Company") of his decision not to stand for re-election to the Board of Directors of the Company (the "Board") when his current term expires on the date of the Company's 2023 Annual Meeting of Stockholders. Mr. Sansone's decision is based solely on personal reasons and not because of any disagreement or dispute with the Board or the Company on any matter, including with respect to the Company's operations, policies or practices.

**Item 9.01 - Financial Statements and Exhibits**

**(d) Exhibits**

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>Description</u>** |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| INFUSYSTEM HOLDINGS, INC. | INFUSYSTEM HOLDINGS, INC. |
| By: | /s/ Barry Steele |
|  | Barry Steele |
|  | Chief Financial Officer |

---

Dated: March 24, 2023